PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $41,753,395 | +26.8% | 1,732,506 | -44.4% | 0.00% | +100.0% |
Q4 2022 | $32,941,152 | +465.5% | 3,116,476 | +140.8% | 0.00% | – |
Q3 2022 | $5,825,000 | +20.4% | 1,294,425 | +7.0% | 0.00% | – |
Q2 2022 | $4,837,000 | -48.2% | 1,209,189 | -5.1% | 0.00% | – |
Q1 2022 | $9,331,000 | +36.9% | 1,274,666 | +5.1% | 0.00% | – |
Q4 2021 | $6,815,000 | -25.3% | 1,212,710 | -14.9% | 0.00% | – |
Q3 2021 | $9,125,000 | -18.5% | 1,425,738 | +7.3% | 0.00% | -100.0% |
Q2 2021 | $11,198,000 | -1.7% | 1,328,337 | +22.4% | 0.00% | 0.0% |
Q1 2021 | $11,393,000 | -32.5% | 1,085,609 | +9.0% | 0.00% | 0.0% |
Q4 2020 | $16,872,000 | +27.3% | 995,965 | -3.6% | 0.00% | 0.0% |
Q3 2020 | $13,256,000 | +8.5% | 1,033,239 | +19.4% | 0.00% | 0.0% |
Q2 2020 | $12,214,000 | +6839.8% | 865,599 | +4431.9% | 0.00% | – |
Q1 2020 | $176,000 | -48.1% | 19,100 | -16.0% | 0.00% | – |
Q4 2019 | $339,000 | +189.7% | 22,730 | +32.9% | 0.00% | – |
Q3 2019 | $117,000 | – | 17,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |